Read More

Cannabis Chart Of The Week: Who Are The Strongest MSO Credits And How Are They Trending?

The Viridian Credit Tracker model is a valuable tool for investors and companies alike to gauge the credit quality of cannabis companies. The model utilizes 11 market-based and financial statement-based variables to measure four critical attributes of credit quality: Liquidity, Leverage, Profitability, and Size.

MRMD

Read More

Viridian Chart Of The Week: Which Companies Have The Most Upside And Downside From A DEA Announcement?

The MSOS ETF is now up 41.4% from the August 30, 2023, HHS rescheduling announcement, but it has fallen significantly from its peak gain of 85.0% in mid-September. The Viridian Chart of the Week looks at the potential upside and downside of the top 15 MSOs concerning a DEA announcement on rescheduling.

AAWH

Read More

Viridian Chart Of The Week: A Valuable Investor Tool To Track Cannabis Credit Quality

Monitoring the credit quality of portfolio companies has become critical in the capital-starved environment of 2023, and, in fact, credit analysis has become the new equity analysis. Credit quality is multidimensional by nature: The Viridian Credit Tracker Model uses 11 market and financial variables to quantify four main credit factors: Liquidity, Leverage, Profitability, and Size, each o

ACRDF

Read More

Cannabis Chart Of The Week: How Much Will MSOs Save In Taxes From Elimination Of 280e?

One of the most important results of the potential rescheduling of cannabis to Schedule 3 is eliminating 280e taxes. In previous charts of the week, we have shown that 280e significantly negatively impacts cannabis companies by reducing their internally funded growth and limiting their debt capacity.

AAWH

Read More

Cannabis Chart Of The Week: How Much Run Is Left In MSO Valuation Multiples?

The MSOS ETF (ARCA: MSOS) gained 69.4% between 8/25/23, five days before the blockbuster announcement of an HHS rescheduling recommendation to this past Friday, 9/8/23. Similarly, the EV/Next-Twelve-Month consensus EBITDA multiples for the group in the chart have increased by 27.5%.

AAWH